Ocugen, Inc. (OCGN) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ocugen, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.071 -- 00:00:04.635 Good morning and welcome to Occugen's second quarter 2036 financial results and business 00:00:04.635 -- 00:00:07.718 update. All participants are in listen-only mode. 00:00:07.718 -- 00:00:11.261 Following the speaker's commentary, there will be a question-and-answer session. 00:00:11.261 -- 00:00:14.685 I will now turn the call over to Chris Clark, Occugen's head of communications. 00:00:14.685 -- 00:00:16.646 You may begin. 00:00:16.646 -- 00:00:19.509 Thank you, operator, and good morning, everyone. 00:00:19.509 -- 00:00:22.472 Joining me on today's call and webcast is Dr. 00:00:22.472 -- 00:00:27.798 Shankar Musunuri. Occugen, Chairman, CEO, and Co-Founder, who will provide a business 00:00:27.798 -- 00:00:32.040 update and an overview of our clinical and operational progress. 00:00:32.040 -- 00:00:36.801 Rita Johnson-Greene, our Chief Financial Officer, is also on the call to provide a financial 00:00:36.801 -- 00:00:41.742 update for the quarter ended June 30th, 2026. 00:00:41.803 -- 00:00:46.165 Abhi Gupta, Executive Vice President of Commercial and Business Development, and Dr. 00:00:46.165 -- 00:00:51.026 Mohamed Genead, who joined Occugen as Chief Medical Officer in June, will be available 00:00:51.026 -- 00:00:54.243 to answer questions following the presentation. 00:00:54.243 -- 00:00:58.784 This morning we issued a press release covering our business and operational highlights 00:00:58.784 -- 00:01:01.745 for the second quarter of 2026. We 00:01:01.745 -- 00:01:06.346 encourage listeners to review the press release, which is available on our website at 00:01:06.346 -- 00:01:08.346 ocugen.com. 00:01:09.227 -- 00:01:13.769 A replay of this call, along with the accompanying slide presentation, will be available 00:01:13....